The Significance of the Severity Index of Epidermolysis Bullosa in Newborns in the Conditions of the Fergana Valley of Uzbekistan

Farrukhbek Khamidov; Ayubova Nargiza; M.Z. Khamidova

doi:10.51699/cajmns.v7i3.3318

Authors

Farrukhbek Khamidov Candidate of Medical Sciences, PhD, Teacher, Department of Dermatovenereology Andijan State Medical Institute, Andijan, Uzbekistan
Ayubova Nargiza Assistant, Department of Dermatovenerology and Cosmetology Tashkent State Medical University, Tashkent, Uzbekistan
M.Z. Khamidova Andijan State Medical Institute

DOI:

https://doi.org/10.51699/cajmns.v7i3.3318

Keywords:

Epidermolysis bullosa, newborns, severity index, Colostrum, AVM Neo, treatment effectiveness

Abstract

This study evaluates the significance of the Epidermolysis Bullosa Severity Index in newborns from the Fergana Valley of Uzbekistan. The effectiveness of comprehensive treatment using Colostrum and AVM Neo was assessed. The findings demonstrated a significant reduction in disease severity and confirmed the usefulness of the severity index for diagnosis and treatment monitoring.

References

V. P. Adaskevich, Diagnostic Indices in Dermatology. Moscow: Panfilov Publishing House; BINOM. Knowledge Laboratory, 2014, 352 pp.

V. I. Albanova, “Bullous epidermolysis: the first year of life,” Russian Journal of Perinatology and Pediatrics, vol. 55, no. 3, pp. 110–117, 2010.

V. I. Albanova, A. E. Karamova, V. V. Chikin, and A. A. Mineeva, “Medical Cell Technologies in the Treatment of Patients with Recessive Dystrophic Bullous Epidermolysis. The Method of Intradermal Administration of Fibroblasts,” Bulletin of Dermatology, no. 3, pp. 46–53, 2015.

N. V. Benova, K. I. Grigoriev, and K. V. Kovalenok, “Care for Children with Bullous Epidermolysis: Palliative Approaches to the Problem,” Medical Nurse, no. 8, pp. 36–44, 2013.

A. A. Kubanov, A. E. Karamova, and E. S. Monchakovskaya, “Congenital bullous epidermolysis: modern methods of diagnosis and treatment,” Perspectives in Regenerative Medicine. Bulletin of Dermatology and Venereology, vol. 96, no. 1, pp. 10–17, 2020.

A. A. Kubanov, A. E. Karamova, and V. V. Chikin, “Epidemiology and the State of Medical Care for Patients with Congenital Bullous Epidermolysis in the Russian Federation,” Bulletin of the Russian Academy of Medical Sciences, vol. 73, no. 6, pp. 420–430, 2018.

N. V. Makhneva, “On the Diagnosis and Treatment of Congenital Bullous Epidermolysis,” Advances in Modern Natural Science, no. 12, pp. 41–43, 2011.

National Clinical Protocol for Prevention and Rehabilitation for the Nosology “Congenital Bullous Epidermolysis”, Order No. 107 of March 29, 2024, Ministry of Health of the Republic of Uzbekistan, 2024.

G. B. Pyagay and N. S. Ibragimova, “The Importance of Interdisciplinary Continuity in the Diagnosis and Management of Patients with Epidermolysis Bullosa,” Dermatovenerology and Aesthetic Medicine, no. 1 (69), pp. 150–153, 2026.

A. B. Rakhmatov and D. Kh. Abdieva, “A case of a borderline form of epidermolysis bullosa,” Dermatovenerology and Aesthetic Medicine, no. 4, pp. 111–113, 2020.

A. B. Rakhmatov, M. K. Khaltarbekov, K. A. Abdullakhodzhaev, and Sh. Sh. Khonkhodzhaev, “A Case of Epidermolysis Bullosa,” Dermatology, Venereology, and Aesthetic Medicine, no. 4, pp. 105–107, 2020.

A. B. Rakhmatov and M. K. Khaltarbekov, “Methods of topical therapy for patients with congenital epidermolysis bullosa,” Dermatovenerology and Aesthetic Medicine, no. 3 (67), p. 23, 2025.

J. D. Fine, R. A. Eady, E. A. Bauer, et al., “The classification of inherited epidermolysis bullosa (EB): Report of the Third International Consensus Meeting on Diagnosis and Classification of EB,” J. Am. Acad. Dermatol., vol. 58, pp. 931–950, 2008.

C. Moss, A. Wong, and P. Devis, “The Birmingham epidermolysis bullosa severity score: development and validation,” Br. J. Dermatol., vol. 160, pp. 1057–1065, 2009.

K. Tamai, I. Hashimoto, et al., “Japanese guidelines for the diagnosis and treatment of junctional and dystrophic epidermolysis bullosa,” Arch. Dermatol. Res., vol. 295, pp. 24–28, 2003.